Tag: Arlene Davis
NC JOLT Symposium – Vaccines: Legal, Political, & Policy Implications from the Advent of Vaccines to the Covid-19 Pandemic
Symposia NC JOLT’s annual symposia focus on cutting-edge legal issues in a wide array of technology-related topics. These symposia are open to UNC students and staff, NCBA members seeking CLE credit, and members of the public. The 2022 Symposium Vaccine Laws, Politics, and Policies: How Did We Get Here and Where Should We Go? … Read more
Hospital Policies During COVID-19: An Analysis of Visitor Restrictions
Abstract Objective: In response to the COVID-19 pandemic, hospitals have developed visitor restriction policies in order to mitigate spread of infection. We reviewed hospital visitor restriction policies for consistency and to develop recommendations to highlight fair and transparent restrictions, exceptions, and appeals in policy development and implementation. Design: Collection and analysis of public-facing visitor restriction … Read more
Arlene Davis Named Director of UNC Center for Bioethics
Arlene M. Davis, JD, associate professor in the UNC Department of Social Medicine and director of the Clinical Ethics Service at UNC Hospitals, has been named director of the UNC Center for Bioethics, effective July 1. “I look forward to my director role in Center. Our core faculty members are outstanding and the Center’s research, … Read more
Passing the Torch at the UNC Center for Bioethics!
I am happy to announce that after 11 years as Director of the UNC Center for Bioethics, I am turning over that leadership role to Arlene Davis, RN, JD, effective July 1, 2021. It has been immensely fulfilling to oversee the flourishing of the C:B over the last decade. I am deeply grateful to the … Read more
Reconsidering Scarce Drug Rationing: Implications for Clinical Research
Hospital systems commonly face the challenge of determining just ways to allocate scarce drugs during national shortages. There is no standardised approach of how this should be instituted, but principles of distributive justice are commonly used so that patients who are most likely to benefit from the drug receive it. As a result, clinical indications, … Read more
A New Governance Overnance Approach to Regulating Human Genome Editing
For years, genomic medicine—medicine based on the growing understanding of the genetic contribution to many diseases and conditions—has been hailed as the future of medical treatment, but it has thus far had limited effect on day-to-day medical practice. The ultimate goal of genomic medicine has always been the ability not just to identify dangerous gene … Read more